ser-155
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2021 (NCT04995653)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06801067 | Phase 1 | Jan 24, 2025 | Memorial Sloan-Kettering Cancer Center |
| NCT04995653 | Phase 1 | Sep 30, 2021 | Memorial Sloan-Kettering Cancer Center, Seres Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 2 | 1 | 1 | 2021 |
| Seres Therapeutics | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1